Epygenix Therapeutics Initiates Phase 2 Study for Dravet Syndrome With EPX-100

Read Full Press Release Here:

https://www.prnewswire.com/news-releases/epygenix-therapeutics-initiates-phase-2-study-for-dravet-syndrome-with-epx-100-301133241.html